Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
National Lipid Associations 2nd Annual Masters Summit during the week of the 80th Scientific Sessions of the American Heart Association
The Role of the Digestive Tract in Lipid Metabolism and Cardiovascular Risk
Orlando, Florida / November 3, 2007
INTRODUCTION Advances in the understanding of the biology of cholesterol metabolism have led to a greater knowledge of how LDL levels can be most effectively reduced to targets now recommended by current guidelines. Whilst the most...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Abnormalities in Mineral Metabolism: Improving Quality of Life for Chronic Kidney Disease Patients
San Francisco, California / November 2-5, 2007
San Francisco - Abnormalities in mineral metabolism are common in chronic kidney disease (CKD), increasing in prevalence and severity as patients remain on dialysis. The most important of these mineral abnormalities are elevations in serum...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Paradigm Shift in the Treatment of Kidney Disease: SMART Findings
San Francisco, California / November 2-5, 2007
San Francisco - Proteinuria is an independent risk factor for progression of both diabetic and non-diabetic kidney disease as it likely contributes to worsening fibrosis and renal impairment. Lowering proteinuria levels in turn reduces the...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Hyperphosphatemia and the Dialysis Patient: Focus on Reducing Calcification
San Francisco, California / November 2-5, 2007
San Francisco - Elevated phosphorus levels occurring at kidney failure are associated with increased vascular calcification and cardiovascular events. Presently, in dialysis patients, hyperphosphatemia is usually managed with phosphate...
Canadian Cardiovascular Congress 2007
High-risk Concept: Management Paradigm Shift from Treatment to Prevention
Quebec City, Quebec / October 20-24, 2007
Quebec City - Better stratification of cardiovascular (CV) risk in asymptomatic patients is becoming increasingly urgent due to the evidence that effective treatments can change the natural history of vascular diseases. In patients with...
Canadian Cardiovascular Congress 2007
The Pillars of ACS Treatment: Assess Risk, Address Ischemia, Prevent Bleeding, Protect Long-Term
Quebec City, Quebec / October 20-24, 2007
Quebec City - Appropriate treatment of acute coronary syndromes (ACS) requires a comprehensive assessment of the patient’s risk for further ischemia and cardiovascular events. Inadequate attention to risk stratification can lead to...
Canadian Cardiovascular Congress 2007
Revisiting Best Evidence-based Care: New Findings on Drug-eluting Stents
Quebec City, Quebec / October 20-24, 2007
Quebec City - Concerns about the safety of drug-eluting stents (DES) led to the development of joint recommendations on their use issued by the CAIC/CCS earlier this year. Since then, long-term follow-up findings from the C-SIRIUS cohort...
Canadian Cardiovascular Congress 2007
Targeting the culprit behind cardiometabolic risk: Strategies to reduce abdominal obesity
Quebec City, Quebec / October 20-24, 2007
INTRODUCTION Physicians have long relied on the Framingham risk assessment score to identify patients at high risk for cardiovascular (CV) events. This score is still useful as a baseline measurement of future risk but it does not take...
Canadian Cardiovascular Congress 2007
Improving Cardiovascular Protection with New Targets and Strategies
Quebec City, Quebec / October 20-24, 2007
Quebec City - Protection of the kidneys, heart and brain is the primary goal of antihypertensive therapy but considerable debate remains as to whether any single antihypertensive agent or class of agents is associated with protective...